These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 2876957)

  • 1. Surface proteins of Bordetella pertussis: comparison of virulent and avirulent strains and effects of phenotypic modulation.
    Armstrong SK; Parker CD
    Infect Immun; 1986 Nov; 54(2):308-14. PubMed ID: 2876957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surface proteins of Bordetella pertussis.
    Parker CD; Armstrong SK
    Rev Infect Dis; 1988; 10 Suppl 2():S327-30. PubMed ID: 2903539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pertussis toxin and extracytoplasmic adenylate cyclase as virulence factors of Bordetella pertussis.
    Weiss AA; Hewlett EL; Myers GA; Falkow S
    J Infect Dis; 1984 Aug; 150(2):219-22. PubMed ID: 6088647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on phase variation in Bordetella pertussis.
    Goldman S; Hanski E; Fish F
    Dev Biol Stand; 1985; 61():255-64. PubMed ID: 2872111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular aspects of Bordetella pertussis pathogenesis.
    Locht C
    Int Microbiol; 1999 Sep; 2(3):137-44. PubMed ID: 10943406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of murine lung inflammation after infection with parental Bordetella pertussis and mutants deficient in adhesins or toxins.
    Khelef N; Bachelet CM; Vargaftig BB; Guiso N
    Infect Immun; 1994 Jul; 62(7):2893-900. PubMed ID: 7999145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lethal infection by Bordetella pertussis mutants in the infant mouse model.
    Weiss AA; Goodwin MS
    Infect Immun; 1989 Dec; 57(12):3757-64. PubMed ID: 2572561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase variation in Bordetella pertussis by frameshift mutation in a gene for a novel two-component system.
    Stibitz S; Aaronson W; Monack D; Falkow S
    Nature; 1989 Mar; 338(6212):266-9. PubMed ID: 2537932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tn5-induced mutations affecting virulence factors of Bordetella pertussis.
    Weiss AA; Hewlett EL; Myers GA; Falkow S
    Infect Immun; 1983 Oct; 42(1):33-41. PubMed ID: 6311749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new assay for invasion of HeLa 229 cells by Bordetella pertussis: effects of inhibitors, phenotypic modulation, and genetic alterations.
    Lee CK; Roberts AL; Finn TM; Knapp S; Mekalanos JJ
    Infect Immun; 1990 Aug; 58(8):2516-22. PubMed ID: 2370104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous phase variation in Bordetella pertussis is a multistep non-random process.
    Goldman S; Hanski E; Fish F
    EMBO J; 1984 Jun; 3(6):1353-6. PubMed ID: 6086320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Selection of Bvg- variants of Bordetella pertussis].
    Passerini de Rossi BN; Friedman LE; Darnaud S; de Torres RA; Franco MA
    Rev Argent Microbiol; 1997; 29(2):75-83. PubMed ID: 9424628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The vir locus and phase-variation in Bordetella pertussis.
    Stibitz S; Aaronson W; Monack D; Falkow S
    Tokai J Exp Clin Med; 1988; 13 Suppl():223-6. PubMed ID: 2908523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of antibodies against Bordetella pertussis virulence factors in adherence of Bordetella pertussis and Bordetella parapertussis to human bronchial epithelial cells.
    van den Berg BM; Beekhuizen H; Mooi FR; van Furth R
    Infect Immun; 1999 Mar; 67(3):1050-5. PubMed ID: 10024542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 23-kilodalton protein, distinct from BvgA, expressed by virulent Bordetella pertussis binds to the promoter region of vir-regulated toxin genes.
    Huh YJ; Weiss AA
    Infect Immun; 1991 Jul; 59(7):2389-95. PubMed ID: 2050404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the promoter fusion transposon Tn5 lac to identify mutations in Bordetella pertussis vir-regulated genes.
    Weiss AA; Melton AR; Walker KE; Andraos-Selim C; Meidl JJ
    Infect Immun; 1989 Sep; 57(9):2674-82. PubMed ID: 2569447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heat-modifiable envelope proteins of Bordetella pertussis.
    Armstrong SK; Parker CD
    Infect Immun; 1986 Oct; 54(1):109-17. PubMed ID: 2875949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chick embryo, a model to study the lethal activity of pertussis toxin, infectivity of Bordetella pertussis, and their neutralization by immune sera.
    Calver GA; Burton WW; Gardell CY
    Can J Microbiol; 1993 Aug; 39(8):759-66. PubMed ID: 8106134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological characterization of the lipooligosaccharide B band of Bordetella pertussis.
    Martin D; Peppler MS; Brodeur BR
    Infect Immun; 1992 Jul; 60(7):2718-25. PubMed ID: 1377181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure and biological properties of solubilized envelope proteins of Bordetella pertussis.
    Robinson A; Hawkins DC
    Infect Immun; 1983 Feb; 39(2):590-8. PubMed ID: 6299946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.